Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Al-NOTA-MATBBN PET/CT in Breast and Prostate Cancer Diagnosis
NCT03094897Phase 1Unknown
- Sponsor
- The Affiliated Hospital of Jiangnan University
- Start
- Apr 2017
- Primary completion
- Dec 2020
- Modality
- Peptides
01
Overview
Phase 1, open-label, single-arm trial of 18F-Al-NOTA-MATBBN in breast cancer and prostate cancer (PCa), sponsored by The Affiliated Hospital of Jiangnan University. Primary endpoint: Standardized uptake value at 1 day. Status: unknown.
02
Drugs
18F-Al-NOTA-MATBBN
03
Conditions
breast cancerprostate cancer (PCa)
Beyond the preview
Go deeper on NCT03094897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03094897.